Factor Bioscience Inc News Today

-Patented methods relate to multiple allogeneic CAR T-cell therapies under clinical development for the treatment of B-cell lymphoma, chronic lympho

Lineage Cell Therapeutics, Inc. ; class=js-l-obf link link--blue

NEW YORK, NY / ACCESSWIRE / December 20, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued

Factor Bioscience to Deliver Six Digital Presentations at the American Society of Gene & Cell Therapy (ASGCT) 24th Annual Meeting -The presentations will reveal advances in mRNA, circleRNA, gene editing, cell reprogramming, and iPS cell-derived NK-cell technologies. - Factors participation in this years ASGCT Annual Meeting marks the companys ten-year anniversary and represents the most comprehensive presentation of the companys data to date. News provided by Share this article Share this artic...